| European Case Law Identifier: | ECLI:EP:BA:2014:T037011.20140819 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 19 August 2014 | ||||||||
| Case number: | T 0370/11 | ||||||||
| Application number: | 03796701.5 | ||||||||
| IPC class: | A61K 31/444 A61K 31/454 A61P 1/00 A61P 9/00 A61P 11/00 A61P 15/00 A61P 29/00 A61P 31/00 A61P 33/00 A61P 37/00 A61P 43/00 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | INHIBITION OF INFLAMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS | ||||||||
| Applicant name: | The Feinstein Institute for Medical Research | ||||||||
| Opponent name: | AstraZeneca AB | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Reimbursement of appeal fee (partly) - withdrawal of patent proprietor's appeal Admissibility of opponent's appeal (no) - missing statement of grounds |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t110370eu1.html
Date retrieved: 17 May 2021